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Hypertension aﬀects about 65 million individuals in the United States. In adult patients, primary aldosteronism and renovascular
causes are described as most prevalent. Vesicoureteral reﬂux as a cause of hypertension, while commonly described in pediatric
populations, is less prevalent in the adult population especially in the absence of proteinuria. We present the case of a 31-year-old
female presenting with early onset hypertension. Workup for renovascular hypertension was unrevealing. She was found to have
right-sided vesicoureteral reﬂux with a unilateral scarred kidney. Patient underwent a nephrectomy with marked improvement in
blood pressure control.
1.Introduction
The absolute number and percentage of adults with hyper-
tension was estimated to be at least 65 million and 31.3%,
respectively, in the US from years 1999-2000 [1]. In the adult
population, 5–10% cases of hypertension are identiﬁed to be
due to secondary causes such as renal parenchymal disease
from diabetes or hypertension, ﬁbromuscular dysplasia, ath-
erosclerotic disease, primary aldosteronism, pheochromocy-
toma, Cushing’s disease, hypo/hyperthyroidism, hyperpara-
thyroidism, and obstructive sleep apnea [2].
Vesicoureteral reﬂux (VUR) is a less recognized cause of
hypertension in the adult population. It is a congenital
anomaly of the ureterovesical junction due to deﬁciency of
the submucosal longitudinal muscle that predisposes the
individual to retrograde urine reﬂux. Adult presentation
of primary VUR occurs in patients who have had VUR
since childhood that has remained undetected and presents
in adulthood with complications or patients who develop
VUR in adulthood de novo with no prior history of UTI
[3]. Primary VUR occurs in the absence of any underlying
pathology, while secondary VUR in the adult occurs due to
conditionssuchasobstruction,previoussurgicalprocedures,
or a neurological disorder [3]. Long-term sequalae include
end-stage renal disease, proteinuria, hypertension, urinary
tract infections, and renal calculi [3–5]. Incidence of hyper-
tension in adults with reﬂux nephropathy has been reported
to be anywhere between 38–60% [4–9] often associated with
proteinuria. We present a case of a 31-year-old female who
had right-sided VUR with a scarred right kidney as the cause
of her underlying hypertension.
2. Case Presentation
A 31-year-old female with onset of hypertension in adoles-
cence initially presented to us with a recent history of hyper-
tensiveurgencyandpriorhistoryofsystolicbloodpressureof
220mm of Hg. She had been started on Amlodipine 10mg
once daily by her primary care physician and referred to
the University Nephrology Clinic. Past medical history was
signiﬁcant for workup for secondary hypertension through
a local nephrology practice approximately nine years ago. At
thattime,renalarterystenosis wasconsideredthe mostlikely
diagnosis and was pursued with invasive testing. She under-
went a renal arteriogram at that time which did not reveal
stenosis. Careful history by us, however, revealed recurrent
urinary tract infections and back pain accompanying these
episodes which aroused our suspicion for a diagnosis of py-
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Her family history was signiﬁcant for middle age onset
of primary hypertension in her father; her mother was
diagnosed with autosomal dominant polycystic kidney dis-
ease leading to end-stage renal disease. She was sexually
active with no use of oral contraceptives. On presentation
to us, her physical examination revealed blood pressure of
153/97mmHg, equal in both arms, and with strong pulses
in upper and lower extremities. The remainder of the phys-
ical examination was essentially unremarkable; no femoral,
carotid, or abdominal bruits were appreciated.
Urinalysis revealed 2+ leukocyte esterase, positive for ni-
trites, trace protein, trace blood, and white blood cell count
of 47. Her complete blood count and basic metabolic panel
were unremarkable. Serum creatinine was 0.7mg/dL, and
24-hour urine protein was 0.24gm/24 hours (<0.2gm/24
hours).
Ultrasoundofthekidneysshowedarightkidneymeasur-
ing 7.8cm with severe cortical thinning and the left kidney
measuring 13.2cm with normal cortical echogenicity. There
was no evidence of hydronephrosis or renal calculi. Real-
time sonographic, duplex, and color Doppler images of the
kidneys demonstrated a scarred right kidney. Doppler of
renal arteries did not show renal artery stenosis. A void-
ing cystourethrogram demonstrated grade-3, right vesicour-
eteral reﬂux. There was also focal narrowing of the right
ureterovesical junction. The bladder was within normal lim-
its. Nuclear imaging to evaluate renal ﬂow showed prompt
radiopharmaceutical uptake within the left kidney. The right
kidney was not clearly visualized on ﬂow phase or functional
images. On delayed imaging, there was reﬂux into the right
collecting system.
She was started on hydrochlorothiazide 25mg once daily
by mouth. Angiotensin converting enzyme inhibitors were
not used due to the patient being sexually active without use
of contraception. Subsequently, surgical opinion was sought
regarding possible nephrectomy. The patient underwent a
laparoscopic right nephrectomy and partial ureterectomy
successfully. Microscopic analysis of the kidney revealed
chronicpyelonephritisandextensivecorticalatrophy.Atfour
month followup, the patient demonstrated excellent blood
pressure control at 118/88mm of Hg while maintained on
hydrochlorothiazide 12.5mg once daily by mouth.
3. Discussion
3.1. VUR and Hypertension in Children. Secondary hyper-
tension is more common in the pediatric population. 60–
80% of secondary hypertension is caused by renal parenchy-
mal disease [10]. VUR, multicystic dysplastic kidney, ureter-
opelvic junction obstruction, and posterior urethral valves
have been associated with hypertension [11]. VUR is one of
the most common causes of severe hypertension in children
[6, 10–13].
VUR was noted in 29% to 50% of children with UTIs,
often the initial presentation [14]. The prevalence of hyper-
tension in children with primary vesicoureteral reﬂux was
estimated to increase with age: it was 1.7% for patients aged
1 year to 9.9 years, 1.8% for adolescents aged 10 years to
14.9 years, 4.7% for patients aged 15 years to 19.9 years, and
35% for patients >20 years of age [15]. It was estimated that
50% of patients with unilateral and bilateral renal damage
would be hypertensive at about 30 and 22 years of age,
respectively [15]. Hypertension was strongly associated with
renal scarring, and VUR increases renal scarring [6, 15].
3.2.VURandHypertensioninAdults. Incidenceofhyperten-
sion in adults with reﬂux nephropathy has been reported to
be anywhere between 38–60% [4–9]. A retrospective study
reported nearly 60% of patients with VUR had hypertension
at presentation; it was signiﬁcantly associated with the pres-
enceof>1g/dayofproteinuria,althoughtheexactnumberof
patients who had both proteinuria and hypertension was not
reported [5]. Studies have reported an inherent relationship
between hypertension and proteinuria in patient who have
VUR [9]. This was not the case with our patient. Our patient
had a 24-hour urine protein of 0.24gm/24 hours.
To our knowledge, only one study in adults so far has
reported serious consideration of VUR as a secondary cause
hypertension in the absence of renal injury markers. In a
study by Barai et al., 19.1% of adult patients with hyperten-
sion who do not have any evidence of renal involvement had
VUR and are often labeled as having essential hypertension
[16]. An editorial did criticize this study as none of the
patients had frequent UTI’s, an inherent selection bias may
have existed as none of the patients had an indication
to have a direct radionuclide voiding cystoscintigraphy
(DRVC) performed, and, lastly, that no imaging study was
performed to evaluated renal scarring [17]. For our patient,
we performed a real-time sonographic, duplex, and color
doppler images of the kidneys which did reveal a scared right
kidney.
3.3. Cause. In the absence of proteinuria, the underlying
causeofhowVURandascarredkidneycausehypertensionis
unclear. Past studies have suggested that reﬂux nephropathy
can activate the renin angiotensin system. In children, it
has been shown that patients with VUR have high circu-
lating or selective renal vein renin levels [10]. One study
suggestednoconsistentevidencetosupporttheroleofrenin-
angiotension and hypertension in patients with unilateral
reﬂuxnephropathy[18].Anotherstudyshowedupregulation
of angiotensin II receptors in reﬂux nephropathy [19].While
one study from Spain showed genetic polymorphisms of
renin-angiotensin-aldosterone (RAS) components are not
independent prognostic indicators of renal scarring in pa-
tients with VUR [20], another study from Taiwan showed
that angiotensin-converting enzyme gene polymorphisms
were associated with progressive renal deterioration in Tai-
wanese children with VUR [21].
3.4. Diagnosis. Guidelines for diagnosis of VUR in the adult
population have been devised with reference to the screening
for VUR in the pediatric population [3] .Ar e c e n tr e v i e w
article stated that voiding cystourethrography is the gold
standard in reﬂux diagnosis in the pediatric population
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evaluation followed by micturating cystourethrogram, radi-
onuclide cystography, intravenous pyelography, ultrasound,
CT, and MRI [3]. Barai et al. did mention that, in patients
whodonothaveanysignsofrenalparenchymalandrenovas-
cular injury as demonstrated by negative serum creatinine,
captopril renography, and urinalysis for proteinuria, studies
such as DRVC should be included as part of a workup for
VUR [16]. They, however, recommended further retrospec-
tive studies prior to making DRVC as standard of care in
looking for underlying causes of hypertension.
3.5. Treatment. Treatment options can be surgical or medi-
cal. Medical treatment consists of antimicrobial treatment or
prophylaxis of UTI and treatment of hypertension; however,
long-term antibiotic prophylaxis may not be an ideal option
for a younger patient in whom more deﬁnitive treatment
would be preferred [3].
Surgical options have been well studied in the pediatric
population. Primary ureteral reimplantation, extravesical
and intravesical surgical techniques, ureteroneocystotomy,
and endoscopic subureteral injections are some of the tech-
niques employed in the correction of VUR in the pediatric
population with success rates of 92–98% [23]. In adults,
some studies have reported endoscopic correction using pol-
ytetraﬂuoroethylene (Teﬂon) or dextranomer/hyaluronic
acid copolymer [24], endoscopic trigonoplasty [25], or en-
doscopicsubureteralglutaraldehydecross-linkedcollagenin-
jection [26].
The only two indications for surgical correction of uni-
lateral reﬂux in adults are a history of pyelonephritis with
unsuccessful medical treatments or in women of childbear-
ing age [27]. Recent studies, however, indicate that pregnant
women with low-grade VUR and unscarred kidneys did not
have any signiﬁcant complications except a higher incidence
ofurinarytractinfection,whichwasnotmodiﬁedbyureteric
reimplantation [28]. Surgery, however, has been reported to
havenobeneﬁcialeﬀectonhypertension[29].Arandomized
control trial failed to support the claim that renal function
is improved by surgical correction of VUR in children
with bilateral disease [30]. No recommendations exist for
treatmentspeciﬁcallyforhypertensioninpatientswithVUR.
4. Conclusion
Our patient’s workup was signiﬁcant for recurrent urinary
tract infections, grade 3 vesicoureteral reﬂux, minimal pro-
teinuria, and a scarred kidney. Ultrasound with Doppler and
voiding cystourethrogram were used for diagnosis. Medical
treatment was not an ideal option in our young patient of
child bearing age. A nephrectomy was performed primarily
for persistent hypertension felt to be secondary to the uni-
laterallyscarredkidney.Afternephrectomy,ourpatientdem-
onstrated markedly improved blood pressure control.
Through this case we hope to highlight VUR as a cause
of secondary hypertension. Markers of renal injury such as
elevatedcreatinineandproteinuriamaybeabsent;however,a
scarredkidneyprobablyisthecauseofpatient’shypertension
throughanunknownmechanism.Medicalmanagementmay
not be ideal, and stenting is not the optimal treatment for
a scarred kidney. Nephrectomy may be therapeutic in these
cases. The long-term beneﬁts remain to be seen, and ran-
domized control trials are needed to study the eﬃcacy of sur-
gical versus medical management of VUR in the adult popu-
lation.
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